68 related articles for article (PubMed ID: 20602312)
1. [Validation of the Quality of Life in Alzheimer's Disease (QOL-AD) scale in Mexican patients with Alzheimer, vascular and mixed-type dementia].
Rosas-Carrasco O; Torres-Arreola Ldel P; Guerra-Silla Mde G; Torres-Castro S; Gutierrez-Robledo LM
Rev Neurol; 2010 Jul; 51(2):72-80. PubMed ID: 20602312
[TBL] [Abstract][Full Text] [Related]
2. Association Between Self- and Proxy-Reported Depression and Quality of Life in Mild-Moderate Alzheimer's Disease.
Joe E; Segal-Gidan F; Cummings JL; Galasko D; Tomaszewski Farias S; Johnson DK; Ross L; Yaffe K; Wang X; Schneider LS; Chui H; Ringman JM;
Am J Geriatr Psychiatry; 2024 Jan; 32(1):58-67. PubMed ID: 37827916
[TBL] [Abstract][Full Text] [Related]
3. Depressive, functional status, and neuropsychiatric symptom trajectories before an Alzheimer's disease diagnosis.
Gaugler JE; Hovater M; Roth DL; Johnston JA; Kane RL; Sarsour K
Aging Ment Health; 2014; 18(1):110-6. PubMed ID: 23822174
[TBL] [Abstract][Full Text] [Related]
4. The association between caregiver well-being and care provided to persons with Alzheimer's disease and related disorders.
Hazzan AA; Shannon H; Ploeg J; Raina P; Gitlin LN; Oremus M
BMC Res Notes; 2016 Jul; 9():344. PubMed ID: 27430976
[TBL] [Abstract][Full Text] [Related]
5. New Onset Poststroke Dementia at one Year in Africans.
Ojagbemi A; Bello T; Owolabi M; Baiyewu O
J Geriatr Psychiatry Neurol; 2022 Jul; 35(4):565-573. PubMed ID: 34338063
[TBL] [Abstract][Full Text] [Related]
6. Validation of the Thai QOL-AD version in Alzheimer's patients and caregivers.
Buasi N; Permsuwan U
Australas Med J; 2014; 7(6):251-9. PubMed ID: 25031647
[TBL] [Abstract][Full Text] [Related]
7. A Visual Analog Scale for Self-Reported Quality of Life: A Comparison of VAS and QoL-AD in Older Adults.
Redford E; Heuer S
Alzheimer Dis Assoc Disord; 2023 Oct-Dec 01; 37(4):343-348. PubMed ID: 37738287
[TBL] [Abstract][Full Text] [Related]
8. A Functional Assessment Tool to Distinguish Controls From Alzheimer's Disease in Lima, Peru.
Custodio N; Montesinos R; Chambergo-Michilot D; Herrera-Perez E; Pintado-Caipa M; Seminario G W; Cuenca J; Mesía L; Failoc-Rojas VE; Diaz MM
Am J Alzheimers Dis Other Demen; 2022; 37():15333175221104354. PubMed ID: 35656899
[TBL] [Abstract][Full Text] [Related]
9. Value of Personalized Dementia-Specific Quality of Life Scales: An Explorative Study in 3 European Countries.
Hendriks I; Demetrio R; Meiland FJM; Chattat R; Szcześniak D; Rymaszewska J; Ettema TP; Evans SB; Brooker D; Evans SC; Atkinson T; Farina E; Saibene FL; Gerritsen DL; Dröes RM
Am J Alzheimers Dis Other Demen; 2021; 36():15333175211033721. PubMed ID: 34424058
[TBL] [Abstract][Full Text] [Related]
10. Physical activity attenuates neuropsychiatric disturbances and caregiver burden in patients with dementia.
Christofoletti G; Oliani MM; Bucken-Gobbi LT; Gobbi S; Beinotti F; Stella F
Clinics (Sao Paulo); 2011; 66(4):613-8. PubMed ID: 21655755
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Italian Version of the Caregiver Abuse Screen among Family Caregivers of Older People with Alzheimer's Disease.
Melchiorre MG; Di Rosa M; Barbabella F; Barbini N; Lattanzio F; Chiatti C
Biomed Res Int; 2017; 2017():3458372. PubMed ID: 28265571
[No Abstract] [Full Text] [Related]
12. Utility of a shortened Hasegawa Dementia Scale Revised questionnaire to rapidly screen and diagnose Alzheimer's disease.
Gong Q; Ishii M; Numata O; Xie W; Hirata T
Aging Med (Milton); 2021 Jun; 4(2):109-114. PubMed ID: 34250428
[TBL] [Abstract][Full Text] [Related]
13. A Path Analysis of Dependence and Quality of Life in Alzheimer's Disease.
Garre-Olmo J; Vilalta-Franch J; Calvó-Perxas L; López-Pousa S;
Am J Alzheimers Dis Other Demen; 2017 Mar; 32(2):108-115. PubMed ID: 28110545
[TBL] [Abstract][Full Text] [Related]
14. Physical and cognitive stimulation in Alzheimer Disease. the GAIA Project: a pilot study.
Maci T; Pira FL; Quattrocchi G; Nuovo SD; Perciavalle V; Zappia M
Am J Alzheimers Dis Other Demen; 2012 Mar; 27(2):107-13. PubMed ID: 22495338
[TBL] [Abstract][Full Text] [Related]
15. Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers.
Gómez-Ulloa D; Runken MC; Rodriguez WI; Hernández B; Chivite M; Davis EA; Nisbet P
Drugs Context; 2024; 13():. PubMed ID: 38699065
[TBL] [Abstract][Full Text] [Related]
16. Pacing and lapping movements among institutionalized patients with dementia.
Nakaoka A; Suto S; Makimoto K; Yamakawa M; Shigenobu K; Tabushi K
Am J Alzheimers Dis Other Demen; 2010 Mar; 25(2):167-72. PubMed ID: 20107237
[TBL] [Abstract][Full Text] [Related]
17. Preserved Consciousness in Alzheimer's Disease and Other Dementias: Caregiver Awareness and Communication Strategies.
Warren A
Front Psychol; 2021; 12():790025. PubMed ID: 34950092
[TBL] [Abstract][Full Text] [Related]
18. Reassessment of the dementia diagnosis of Alzheimer's disease in patients enrolled on the cholinesterase inhibitors dispensation program.
Piovesana MCFS; Garcia FR; Carrasco KG; Tognola WA
Dement Neuropsychol; 2012; 6(4):270-275. PubMed ID: 29213808
[TBL] [Abstract][Full Text] [Related]
19. Optimal management of Alzheimer's disease patients: Clinical guidelines and family advice.
Haberstroh J; Hampel H; Pantel J
Neuropsychiatr Dis Treat; 2010 May; 6():243-53. PubMed ID: 20520788
[TBL] [Abstract][Full Text] [Related]
20. Design and Evaluation of a Technological Platform for Monitoring Patients with Dementia: Unifying Requirements from Mexican Day Centers.
Barreras Diaz TA; Esquer-Rochin M; Gutierrez-Garcia JO; Rodriguez LF
J Med Syst; 2023 Feb; 47(1):30. PubMed ID: 36840849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]